Methotrexate is commonly used in rheumatoid arthritis as an anti-inflammatory agent, but treatment with methotrexate can lead to severe side effects, especially pulmonary complication. Interstitial pneumonitis is one of the most important pulmonary adverse effects of methotrexate and most patient present with a subacute febrile illness and peripheral eosinophilia is seen in about a half of patients. Almost all patients have abnormal chest roentgenograms and bibasilar interstitial infiltration with alveolar pulmonary consolidations is the most characteristic finding. Interstitial inflammation with mononuclear cell infiltration is a characteristic pathologic feature and findings that suggest acute hypersensitivity pneumonitis, such as bronchiolitis, granuloma formation with giant cells, and infiltration with eosinophils are often present. Methotrexate-induced pneumonitis is a potentially life threatening and unpredictable complication but it is difficult to make a definite diagnosis in the absence of high index of clinical suspicion. Early recognition and appropriate management may avoid the serious outcome. Herein we report a case of methotrexate-induced pneumonitis in a patient with rheumatoid arthritis.(Tuberc Respir Dis 2004; 57:273-277)
(1951) Therapeutic suppression of tissue reactivity II.Effect of aminophterin in rheumatoid arthritis and psoriasis,
(1985) Efficacy of low- dose methotrexate in rheumatoid arthritis,
(1969) Pulmonary disease complicating intermittent therapy with methotrexate,
(1983) Acute lung disease associated with low- dose pulse methotrexate therapy in patients with rheumatoid arthritis,
(1994) A case of interstitial pneumonitis complicating low dose methotrexate therapy in rheumatoid arthritis,
(1998) A case of methotrexate-associated pneumonitis in rheumatoid arthritis,
(2004) A Case of Hypersensitivity Pneumonitis Caused by Methotrexate,
(1996) Ocurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis,
(1997) Risk factors for methotrexate-induced lung injury in patients in rheumatoid arthritis,
(1997) Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis,
(2002) Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests,
(2000) Methotrexate pneumonitis:review of the literature and histopathological findings in nine patients,
(1997) Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis,
(1999) Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy,
(1997) Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis,